Anthony R. Fehr

SARS-CoV-2 Drug-Resistant Mutations in Non-Structural Proteins

Various antiviral drug therapies have been developed for the treatment of coronaviruses, particularly SARS-CoV-2. However, the emergence of drug-resistant mutations is detrimental to clinical efficacy and global public health. Antiviral usage exerts selective pressures on viruses...